The clinical research landscape is experiencing a significant paradigm shift toward decentralized and hybrid trial models that fundamentally alter how clinical supplies are managed, distributed, and tracked. Decentralized clinical trials (DCTs), which enable patients to participate from their homes rather than visiting central clinical sites, have transitioned from experimental concepts to mainstream methodology. This transformation, […]The post Decentralized Clinical Trials: New Demands on Clinical Supply Strategies first appeared on World Pharma Today.
